News & Perspective

Oct 11, 2019

Oct 11, 2019

ASP Scan (Weekly) for Oct 11, 2019

Probiotics and C diff risk
MCR genes on Algerian farms
Price cut demand for MDR-TB drug
ICU infections in Europe
XDR typhoid in travelers
Post-hospital antibiotic use
Resistant gonorrhea response plan
Urinary antigen testing for pneumonia
C diff testing guidelines challenged
XDR Klebsiella pneumoniae

Mar 15, 2019

Mar 15, 2019

Stewardship / Resistance Scan for Mar 15, 2019

Penicillin allergy de-labeling
Antibiotic misuse in Irish long-term care
Resistant bacteria in imported shrimp

Mar 08, 2019

Mar 08, 2019

ASP Scan (Weekly) for Mar 08, 2019

Home therapy for kids' cellulitis
Antibiotics and UTI relapse
Outpatient surgery overprescribing
Resistance prevalence and sepsis
Resistant gonorrhea strain
Empiric antibiotics and UTI
Surgery-linked resistant Pseudomonas
Preventing healthcare-related infection
Resistance and sustainable development
New CARB-X funding
ESBL prediction models

Feb 21, 2019

Feb 21, 2019

Stewardship / Resistance Scan for Feb 21, 2019

XDR gonorrhea clone
New metallo-beta-lactamase
Fast track for pneumonia antibiotic

Nov 17, 2017

Nov 17, 2017

ASP Scan (Weekly) for Nov 17, 2017

Primary care stewardship
No-touch superbug disinfection
Surgical antimicrobial prescribing
Ceftriaxone-resistant gonorrhea
E coli ST131
Single-room ICU design
ECDC CRE guidance
European research funding
Optimal MDR-TB treatment
Real-time resistance tracker
Salmonella in calves
Drug-resistant malaria controversy
US AMR progress
Antimicrobial use in Northern Ireland
Resistance in space

Nov 10, 2016

Nov 10, 2016
cystic fibrosis

Study describes spread of drug-resistant bug that infects cystic fibrosis patients

The bacterium may have recently evolved to spread person to person, as it becomes more virulent.

Feb 14, 2013

Feb 14, 2013

Euro studies show flu vaccine working best against type B

(CIDRAP News) – New European studies reported today in Eurosurveillance suggest that this year's influenza vaccine is providing good protection against influenza B viruses but only moderate protection against type A—findings more or less consistent with earlier results in the United States.

Apr 05, 2012

Apr 05, 2012

Study: Lax response spurred England's late, severe H1N1 spike

(CIDRAP News) – Lapses in health measures during the second season that the 2009 H1N1 flu virus circulated in England probably contributed to a heavier disease burden—marked by more deaths and hospitalizations—than during the 2009-10 pandemic, researchers reported today.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»